General Atlantic, IDG lead $100m fourth round for Chinese biotech firm Biotheus
Source: National Cancer Institute/Unsplash
March 4, 2021
Biotheus, a Chinese biotech firm focusing on the treatment of malignant tumours and autoimmune diseases, has secured over $100 million in its fourth funding round co-led by growth equity investor General Atlantic and Beijing-based investment firm IDG Capital.
New investors in the round include Chinese private equity (PE) firm Kunlun Capital, CITIC’s asset management firm CPE, and Shenzhen-based PE Cowin Capital, Biotheus said in a statement on Wednesday.
Returning investors such as healthcare-focused investment companies HighLight Capital and Shiyu Capital, Chinese fund manager New Alliance Capital, and Huajin Investment participated in the deal.
Construction begins on Deer Creek Senior Housing in Gainesville
gainesville.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gainesville.com Daily Mail and Mail on Sunday newspapers.
Alliant Strategic Development Appoints Scott Nakaatari as Vice President of LIHTC Development
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.